Defensive bet with macro tailwinds? 5 Indian pharma stocks with upside potential of up to 20% : vimarsana.com

Defensive bet with macro tailwinds? 5 Indian pharma stocks with upside potential of up to 20%

On Tuesday, when the whole market was reeling under pressure, two stocks reacted to their numbers in a positive direction. Both of them were large caps from one sector which is pharma. This becomes significant from three perspectives. First, that positive reaction was there on the day when there was a bloodbath on the street. Second, these stocks were already sitting on gains, so there is little probability of short covering leading to this sort of gains. Last but not the least it has come from sectors like pharma which have seen a very long phase of business remodelling and valuation readjustment, which makes it worth noticing. It might be too early to call, but if a re-rating gets momentum then they might be candidates for volatile markets.

Related Keywords

, Google , Market Research , Unlimited Access , Economic Times , Saver Sale , Membershipclaim Offer , Prime Story , Debit Cards , Includes Docubay , Economic Times Stories , Industry Trends , Virtual Events , Sun Pharmaceutical , Stocks To Buy , Stock Ideas , Pharma Stocks To Buy , Pharma Stocks , Drl Shares , Aurobindo Pharma ,

© 2024 Vimarsana